Comment: trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections

Abstract

Get full access to this article

View all access options for this article.

References

1. Adra

, Lawrence

. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections. Ann Pharmacother 2004; 38: 338–41. DOI 10.1345/aph.1D156

2. Jemni

, Hmouda

, Letaief

. Efficacy of trimethoprim-sulfamethoxazole in the treatment of bacterial endocarditis against clinical isolates of methicillin resistant Staphylococcus aureus: a report from Tunisia. Clin Infect Dis 1994; 19: 202–3.

3.Nosocomial enterococci resistant to vancomycin—United States, 1989–1993. MMWR Morb Mortal Wkly Rep 1993; 42: 597–9.

4. Malbruny

, Canu

, Bozdogan

, Fantin

, Zarrouk

, Vdutka-Malen

, Resistance to quinupristin/dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46: 2200–7.

5. Tsiodras

, Gold

, Sakoulas

, Eliopoulos

, Wennersten

, Venkataraman

, Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001; 358: 207–8.